Related by context. Frequent words. (Click for all words.) 71 VEGFR2 inhibitor 70 MKC# MT 66 MKC# 66 R sorafenib tablets 65 2 methoxyestradiol 65 Small interfering RNAs 64 oncolytic virus therapies 64 Panzem R 64 novel orally administered 64 phenylalanine ammonia lyase 64 PNP inhibitor 64 liposomal formulation 64 sodium Injection 63 sorafenib tablets 63 Æterna Zentaris Inc. 63 cutaneous T 63 refractory chronic lymphocytic 63 includes investigational compounds 63 metastatic colorectal 63 ® bortezomib 63 AEG# 63 apoptosis proteins 63 treat male hypogonadism 63 modulate ion channel 63 DNA RNA Medicines 63 ALN PCS 63 Vytorin combines 62 Voreloxin 62 development diagnostics combinatorial 62 anthracycline taxane 62 By Riva Froymovich 62 Potassium Chloride Sodium Ascorbate 62 based pretargeting methods 62 advanced carcinoid 62 community AABB SmartBrief 62 Genasense ® oblimersen 62 Thiarabine 62 luteinizing hormone releasing 62 huC# DM4 62 By Thomas Gryta 62 SAR# [004] 62 Mipomersen 62 overactive bladder AA# 62 multi kinase inhibitor 62 FUSILEV ® 62 REGN# 61 specific ZFP Nucleases 61 candidate AP# 61 XL# XL# XL# XL# 61 Additionally MorphoSys 61 rheumatoid arthritis psoriatic arthritis 61 immunotherapeutic agent 61 Initiates Phase II 61 Omacetaxine 61 factor VIIa 61 catheter occlusion 61 By Katy Burne 61 injectable depot 61 epothilones 61 Dyax logo 61 Belimumab 61 PDE4 inhibitor 61 targeted immunotherapies 61 developing Zerenex TM 61 GSK# [002] 61 Nasdaq MNKD focuses 61 Marcus Gronholm BP 61 Vidaza R 61 systemically administered 61 XOMA 3AB 61 Panzem R NCD 61 Phase Ib clinical trials 61 By PATRICK BAHR 60 addressing idiopathic pulmonary 60 PEGylated anti 60 gets USFDA nod 60 By HARVEY SIMPSON 60 phenylketonuria PKU developed 60 MEK inhibitor 60 psoriasis rheumatoid arthritis 60 forodesine 60 Completes Patient Enrollment 60 Meets Primary Endpoint 60 relapsed refractory multiple myeloma 60 pramlintide acetate injection 60 candidate ridaforolimus 60 Auxilium transmucosal film 60 Currently RegeneRx 60 signal detection CTSD 60 topical non steroidal 60 RhuDex ® 60 By RICK KRETZSCHMAR 60 candidate brentuximab vedotin 60 proteasome inhibitor 60 Factor VIIa 60 R bortezomib 60 Dacetuzumab 60 Acute Myeloid Leukemia AML 60 vascular disrupting agent 60 Emergent marketed 60 Receives Orphan Drug Designation